AstraZeneca Pharmaceutical
VC Fund
Shanghai, China
AstraZeneca Pharmaceutical is a VC fund in Shanghai focused on Biotechnology and Manufacturing. AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to themedical industry Significant changes.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries AstraZeneca Pharmaceutical invests in
Stages AstraZeneca Pharmaceutical invests in
Countries AstraZeneca Pharmaceutical invests in
Investment Focus
Industry
- Biotechnology 2 (40%)
- Manufacturing 2 (40%)
- Medical Device 2 (40%)
- Medical 1 (20%)
- Health Diagnostics 1 (20%)
Stage
- Series B 2 (40%)
- Series A 1 (20%)
- Series D 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $150M / Series B / Mar 31, 2026 | |
|
|
Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $100M / Series A / Dec 11, 2025 | |
|
|
Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | Series A / Nov 19, 2024 | |
|
|
Axbio manufactures next-generation gene sequencing and diagnostic high-end equipment and providing complete industrial solutions. | $100M / Series B / Jun 20, 2022 | |
|
|
Creativity (Beijing) Medical Technology Development Co., Ltd. is a leading minimally invasive interventional delivery system product full solution provider. Committed to cooperating with top experts at home and abroad in the field of minimally invasive intervention, and cooperating with internationally renowned raw material manufacturers to jointlydevelop, produce and sell leading products. Provide doctors with differentiated diagnosis and treatment tools, relieve patients' pain and reduce medical burden. | Series D / Dec 22, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does AstraZeneca Pharmaceutical invest in?
AstraZeneca Pharmaceutical invests primarily in Biotechnology, Manufacturing and Medical Device startups, most often at Series B and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did AstraZeneca Pharmaceutical last invest?
The most recent investment recorded for AstraZeneca Pharmaceutical closed in Mar 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!